Japan Weekly Strategy Report – Any prescriptions during the trade war? June 25, 2018 1480

Interested to trade in the Japan market?
From 1 Jun – 31 Aug 2018, receive SGD38* when you start trading in the Japan market! Read on for more information! 
*Terms & Conditions Apply.

Trade friction started from the US spreads globally, causing confusion in financial markets. The friction between the US and China intensified, and the Shanghai Composite Index continued its decline, falling below 3,000 on 6/19, its lowest since Sep 2016, and it reached 2875.81 on 6/21. In the US, the Dow declined for 8 consecutive days to 24,461.70 points, falling by 860.61 points (3.40%) during this period and down 1.04% for the year.

The US warned of the application of tariffs on Chinese products with a total value of US$450 billion, which is almost the majority of Chinese exports to the US. From July 6, the US plans to invoke tariffs on 818 items such as China’s industrial robots, electronic parts and cars, which is equivalent to US$34 billion worth of trade. A public hearing to be held on July 24 may see another 284 items equivalent to US$16 billion added from the high priority “Made in China 2025” cluster, such as chemical products, optical fiber, measuring equipment, manufacturing equipment for electronic parts, agricultural machinery, other industrial machinery, and railroads. The US is increasingly criticizing the strategic “Made in China 2025” high-tech industry cluster which China is fostering with huge subsidies.

Meanwhile, China cancelled its plan to increase imports by US$70 billion (7.7 trillion yen) of agricultural products and energy from the US and announced 25% tariffs on 659 items including those items. On Jul 6, China plans to impose tariffs on 545 items including soybeans, beef, pork, chicken, oranges, whiskey, tobacco and cars (including EV) which are worth US$34 billion out of the total US$50 billion effected, and then consider when to activate tariffs on the remaining 114 items including crude oil, natural gas, coal, ethylene and medical instruments, equivalent to US$16 billion. As China accounts for 60% of the exports of US soybeans, the damage to the US may not be small. 

The EU, from Jun 22, imposed retaliatory 25% tariffs on EUR2.8 billion (360 billion yen) of products including steel/aluminum products, agricultural products such as corn and peanuts, bourbon, jeans, motorcycles and so on. Daimler AG announced a downwards revision of its forecast business performance against a backdrop of further US-China trade friction. President Trump’s approval rating has risen to 45%, its highest level since right after the election, and the strong trade policy will probably continue. The stock selection focuses on domestic stocks with good performance, but also picked up trading companies due to the stabilization of crude oil prices, PER and dividend yield level.

In the 25th of Jun issue, we will be covering Yumeshin Holdings (2362), AMBITION (3300), Zeria Pharmaceutical (4559), Sumitomo Osaka Cement (5232), KOITO MANUFACTURING (7276), and Mitsubishi Corp (8058).

 

Selected Stocks

Yumeshin Holdings Co Ltd (2362)

· Established as a construction office in 1970. In addition to the dispatch of construction technicians and engineers, the company is also engaged in education and IT related businesses. In 1985, it established a mechanism to have construction drawings drawn overseas. In 1990, it began outsourcing construction technicians. The company dispatches construction technicians as well as CAD operators.

· For 1H of 2018/9 (October – March), sales increased by 33.2% to 19.338 billion yen, operating profit doubled to 2.587 billion yen, and net profit rose 2.3 times to 1.871 billion yen as compared to the same period the previous year. The scale of dispatching construction technicians and engineers grew by hiring a greater number of technicians. Profits rose due to higher billing per staff and staff utilization rate in the construction technician temporary staffing segment.

· For 2019/9 full year forecasts, sales is expected to increase by 27.8% to 39 billion yen, operating income to increase by 90.5% to 4.5 billion yen, and net income to double to 2.9 billion yen as compared to the previous year. The earthquake that occurred in Osaka prefecture on June 18 exposes the aging of urban infrastructure as seen in damaged water pipes. There may be a higher demand for adopting earthquake proof technology, maintenance and repair work.

Ambition Corp (3300)

· Established in 2007. The company engages in property management, lease brokerage agency services and investment business. Its core business is to provide housing for singles in their 20s to 30s through leasing of residential units. It also purchases residential properties below market value, renovates and sells to the general clients.

· In the 3Q (July – March) of 2018/6, sales increased by 66.3% to 16.558 billion yen, operating profit jumped 9 times to 548 million yen, and net income rose 8.7 times to 268 million yen as compared to the same period the previous year. The property management segment expands steadily. Sales and profits increased dramatically due to the gains from Veritas, a real estate development and planning company which was acquired by Ambition Corp in Oct 2017.

· The 2018/6 full year forecasts have been revised upwards. Sales is expected to increase by 58.8% to 23.143 billion yen (previous forecast was 22.289 billion yen), operating income to increase 3.8 times to 1.108 billion yen (Previously 672 million yen), net income to increase 3.7 times to 547 million yen (Previously 304 million yen). Following the enforcement of a new law governing home-sharing, the reservation rate of the private homes during the non-peak season rose to more than 80-90%.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!